HIV患者普遍抗逆转录病毒治疗的可负担性、成本和成本效益
Affordability, cost and cost-effectiveness of universal anti-retroviral therapy for HIV
摘要：
如果每年对有感染艾滋病毒风险的人进行检测，并在发现艾滋病毒呈阳性时立即开始治疗，就有可能将艾滋病毒的病例复制数减少到1个以下，消除传播并结束这一流行病。如果要做到这一点，就必须知道它是否负担得起，并且具有成本效益。在这里，我们表明，除了11个国家之外，世界上所有国家都能负担得起，在这11个国家，国际社会也能负担得起，在所有国家，它都是高度成本效益的。
英文摘要：
If people at risk of HIV infection are tested annually and started on treatment as soon as they are found to be HIV-positive it should be possible to reduce the case reproduction number for HIV to less than one, eliminate transmission and end the epidemic. If this is to be done it is essential to know if it would be affordable, and cost effective. Here we show that in all but eleven countries of the world it is affordable by those countries, that in these eleven countries it is affordable for the international community, and in all countries it is highly cost-effective.
机构、总结、中文摘要均由AI分析而来，可能存在错误，请以论文正文为准。
